Tuesday, March 20, 2018 4:15:01 PM
.14 looks like quite a barrier at the moment. Yes, I'll be around watching for a potential entry point but I still see lack of funds as an issue. I'm not being negative as I have been around for way too long and still think that there is significant promise for this company. I do wish everyone here well!!
Plus, that .44 price is, IMO, too low. Whatever it is that propels this company well over .30 takes it beyond .44 to who knows where. I suspect that when they can implement some sort of decent revenue stream then this moves and moves well.
Plus, that .44 price is, IMO, too low. Whatever it is that propels this company well over .30 takes it beyond .44 to who knows where. I suspect that when they can implement some sort of decent revenue stream then this moves and moves well.
Recent BICX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 01:31:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 07:31:02 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 07:04:16 PM
- BioCorRx Inc. to Present at the Life Sciences Virtual Investor Forum December 11th • GlobeNewswire Inc. • 12/10/2025 01:35:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for December 11th • GlobeNewswire Inc. • 12/09/2025 01:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:28:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 05:59:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2025 08:15:38 PM
